After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

Ipsen may be a recent entrant into the antibody-drug conjugate space, but the French biopharma is continuing to make up for lost time. The latest addition to the Paris-based company’s portfolio is ...

EY global chief innovation officer, Joe Depa; Cisco SVP & CMO, AI, Networking & Collaboration, Aruna Ravichandran; and billionaire Mark Cuban (left to right).EY/Cisco/John Nacion/Variety via Getty ...

Reese Witherspoon and her three children are getting into the holiday spirit ahead of the Christmas holiday. The Legally Blonde star shared a post capturing the memories she had been making this ...

The Food and Drug Administration has put a partial clinical hold on one of Merck & Co. and Daiichi Sankyo’s antibody-drug conjugates following an unexpected number of deaths in a late-stage clinical ...